Olink

Olink®
Part of Thermo Fisher Scientific

Filters

PublicationDisease areaApplication areaSample typeProducts

Neurobiology of Disease, 2023
Uncovering a neurological protein signature for severe COVID-19

El-Agnaf O., Bensmail I., Al-Nesf M. et al.

Olink Target 96NeurologyInfectious DiseasesPathophysiologyPatient StratificationPlasma

BMC Medicine, 2023
Chemotherapy-induced weight gain in early-stage breast cancer: a prospective matched cohort study reveals associations with inflammation and gut dysbiosis

Walker J., Joy A., Vos L. et al.

Olink Target 96OncologyMetabolic DiseasesPathophysiologyPlasma

Clinical Rheumatology, 2023
Plasma proteomic profiling reveals KRT19 could be a potential biomarker in patients with anti-MDA5+ dermatomyositis

Zhang P., Li M., Zhang Y. et al.

Olink Target 96Immunological & Inflammatory DiseasesPatient StratificationPlasma

International Journal of Molecular Sciences, 2023
Polymorphisms within Autophagy-Related Genes as Susceptibility Biomarkers for Multiple Myeloma: A Meta-Analysis of Three Large Cohorts and Functional Characterization

Clavero E., Sanchez-Maldonado J., Macauda A. et al.

Olink Target 96OncologyPathophysiologyPlasmaSerum

Journal of Clinical Immunology, 2023
Insights into the expanding intestinal phenotypic spectrum of SOCS1 haploinsufficiency and therapeutic options

Rodari M., Cazals-Hatem D., Uzzan M. et al.

Olink Target 48Immunological & Inflammatory DiseasesPathophysiologyPlasma

The American Journal of Human Genetics, 2023
Genome-wide aggregated trans-effects on risk of type 1 diabetes: A test of the “omnigenic” sparse effector hypothesis of complex trait genetics

Iakovliev A., McGurnaghan S., Hayward C. et al.

Olink Target 96Metabolic DiseasesPathophysiologyPlasma

Frontiers in Immunology, 2023
Type 1 interferon signature in peripheral blood mononuclear cells and monocytes of idiopathic inflammatory myopathy patients with different myositis-specific autoantibodies

Li M., Zhang Y., Zhang W. et al.

Olink Target 96Immunological & Inflammatory DiseasesPathophysiologyPlasma

Thrombosis Research, 2023
Unsupervised clustering of venous thromboembolism patients by clinical features at presentation identifies novel endotypes that improve prognostic stratification

Pallares Robles A., ten Cate V., Lenz M. et al.

Olink Target 96CVDPathophysiologyPatient StratificationPlasma

Stress, 2023
The chronic stress risk phenotype mirrored in the human retina as a neurodegenerative condition

Malan L., van Wyk R., von Känel R. et al.

Olink Target 96NeurologyOphthalmologyPathophysiologySerum

Scientific Reports, 2023
Age-dependent differences and similarities in the plasma proteomic signature of postoperative delirium

Oren R., Kim E., Leonard A. et al.

Olink Target 96NeurologyPathophysiologyPatient StratificationPlasma

Hepatology, 2023
Bile exosomal miR-182/183-5p increases cholangiocarcinoma stemness and progression by targeting HPGD and increasing PGE2 generation

Shu L., Li X., Liu Z. et al.

Olink Target 96OncologyPathophysiologyCell Culture Supernatant

Brain, Behavior, and Immunity, 2023
Immunological protein profiling of first-episode psychosis patients identifies CSF and blood biomarkers correlating with disease severity

Eren F., Schwieler L., Orhan F. et al.

Olink Target 96NeurologyPathophysiologyPatient StratificationPlasmaCSF

JACC: Heart Failure, 2023
Myeloperoxidase Inhibition Reverses Biomarker Profiles Associated With Clinical Outcomes in HFpEF

Michaëlsson E., Lund L., Hage C. et al.

Olink Target 96CVDPathophysiologyPatient StratificationPlasma

Nature Communications, 2023
Identification of biomarkers for glycaemic deterioration in type 2 diabetes

Slieker R., Donnelly L., Akalestou E. et al.

Olink Target 96Metabolic DiseasesPatient StratificationPlasma

International Journal of Molecular Sciences, 2023
Blood-Based Proteomic Profiling Identifies Potential Biomarker Candidates and Pathogenic Pathways in Dementia

Ehtewish H., Mesleh A., Ponirakis G. et al.

Olink Target 96NeurologyPathophysiologyPatient StratificationPlasma

Annals of Hematology, 2023
Switching from imatinib to nilotinib plus pegylated interferon-α2b in chronic phase CML failing to achieve deep molecular response: clinical and immunological effects

Geelen I., Gullaksen S., Ilander M. et al.

Olink Target 96OncologyPathophysiology

Science Advances, 2023
Druggable proteins influencing cardiac structure and function: Implications for heart failure therapies and cancer cardiotoxicity

Schmidt A., Bourfiss M., Alasiri A. et al.

Olink Target 96CVDPathophysiologyPlasma

Med, 2023
RNase2 is a possible trigger of acute-on-chronic inflammation leading to mRNA vaccine-associated cardiac complication

Ong E., Koh C., Tng D. et al.

Olink Target 48Immunological & Inflammatory DiseasesPathophysiologySerum

ESC Heart Failure, 2023
Circulating immune checkpoints predict heart failure outcomes

Screever E., Yousif L., Moslehi J. et al.

Olink Target 96CVDPatient StratificationPlasma

Arthritis & Rheumatology, 2023
Preclinical Characterization of Pharmacologic NAD+ Boosting as a Promising Therapeutic Approach in Rheumatoid Arthritis

Perez‐Sanchez C., Escudero‐Contreras A., Cerdó T. et al.

Olink Target 96Immunological & Inflammatory DiseasesPatient StratificationPlasma

1889 publications